Paul Horstmeier - 12 Apr 2022 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role
Chief Operating Officer
Signature
/s/ Jason Alger, as Attorney-in-Fact
Issuer symbol
HCAT
Transactions as of
12 Apr 2022
Net transactions value
-$51,176
Form type
4
Filing time
14 Apr 2022, 20:45:47 UTC
Previous filing
08 Apr 2022
Next filing
03 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCAT Common Stock Options Exercise $8,237 +520 +0.29% $15.84 180,836 12 Apr 2022 Direct
transaction HCAT Common Stock Options Exercise $66,005 +4,167 +2.3% $15.84 185,003 12 Apr 2022 Direct
transaction HCAT Common Stock Options Exercise $5,627 +521 +0.28% $10.80 185,524 12 Apr 2022 Direct
transaction HCAT Common Stock Sale $131,045 -5,208 -2.8% $25.16 180,316 12 Apr 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCAT Stock Option (Right to Buy) Options Exercise $0 -4,167 -11% $0.000000 35,402 12 Apr 2022 Common Stock 4,167 $15.84 Direct F2
transaction HCAT Stock Option (Right to Buy) Options Exercise $0 -520 -8.3% $0.000000 5,728 12 Apr 2022 Common Stock 520 $15.84 Direct F3
transaction HCAT Stock Option (Right to Buy) Options Exercise $0 -521 -2.7% $0.000000 18,474 12 Apr 2022 Common Stock 521 $10.80 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1.
F2 25% of the 186,467 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023.
F3 25% of the 25,000 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023.
F4 25% of the 18,995 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.